All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
CRWD / CrowdStrike Holdings, Inc.
|
|
|
|
|
|
|
|
LYFT / Lyft, Inc.
|
|
|
|
|
|
|
|
ALEC / Alector, Inc.
|
|
|
|
|
|
|
|
FHTX / Foghorn Therapeutics Inc.
|
|
|
|
|
|
|
|
VERA / Vera Therapeutics, Inc.
|
|
|
|
|
|
|
|
FULC / Fulcrum Therapeutics, Inc.
|
|
|
|
|
|
|
|
MOND / Mondee Holdings, Inc.
|
|
|
|
|
|
|
|
DM / Desktop Metal, Inc.
|
|
|
|
|
|
|
|
EXAS / Exact Sciences Corporation
|
|
|
|
|
|
|
|
TCRX / TScan Therapeutics, Inc.
|
|
|
|
|
|
|
|
TNYA / Tenaya Therapeutics, Inc.
|
|
|
|
|
|
|
|
ME / 23andMe Holding Co.
|
|
|
|
|
|
|
|
OPRT / Oportun Financial Corporation
|
|
|
|
|
|
|
|
SANA / Sana Biotechnology, Inc.
|
|
|
|
|
|
|
|
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
OSCR / Oscar Health, Inc.
|
|
|
|
|
|
|
|
GTLB / GitLab Inc.
|
|
|
|
|
|
|
|
PL / Planet Labs PBC
|
|
|
|
|
|
|
|
KRON / Kronos Bio, Inc.
|
|
|
|
|
|
|
|
SNOW / Snowflake Inc.
|
|
|
|
|
|
|
|
RANI / Rani Therapeutics Holdings, Inc.
|
|
|
|
|
|
|
|
FRSH / Freshworks Inc.
|
|
|
|
|
|
|
|
VERV / Verve Therapeutics, Inc.
|
|
|
|
|
|
|
|
PRME / Prime Medicine, Inc.
|
|
|
|
|
|
|
|
HLTH / Cue Health Inc.
|
|
|
|
|
|
|
|
MGTA / Magenta Therapeutics Inc
|
|
|
|
|
|
|
|
EQRX / EQRx Inc
|
|
|
|
|
|
|
|
DBTX / Decibel Therapeutics Inc
|
|
|
|
|
|
|
|
HYPR / Hyperfine, Inc.
|
|
|
|
|
|
|
|
QNCX / Quince Therapeutics, Inc.
|
|
|
|
|
|
|
|
RGEN / Repligen Corporation
|
|
|
|
|
|
|
|
BRNS / Barinthus Biotherapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
/ Evelo Biosciences Inc
|
|
|
|
|
|
|
|
EVLO / Evelo Biosciences, Inc.
|
|
|
|
|
|
|
|
LYEL / Lyell Immunopharma, Inc.
|
|
|
|
|
|
|
|
RAPT / RAPT Therapeutics, Inc.
|
|
|
|
|
|
|
|
PATH / UiPath Inc.
|
|
|
|
|
|
|
|
DUOL / Duolingo, Inc.
|
|
|
|
|
|
|
|
DXCM / DexCom, Inc.
|
|
|
|
|
|
|
|
ILMN / Illumina, Inc.
|
|
|
|
|
|
|
|
LSAQ / LifeSci Acquisition II Corp
|
|
|
|
|
|
|
|
RLAY / Relay Therapeutics, Inc.
|
|
|
|
|
|
|
|
BEAM / Beam Therapeutics Inc.
|
|
|
|
|
|
|
|
NVTAQ / Invitae Corporation
|
|
|
|
|
|
|
|
IVVD / Invivyd, Inc.
|
|
|
|
|
|
|
|
BHIL / Benson Hill, Inc.
|
|
|
|
|
|
|
|
SPRO / Spero Therapeutics, Inc.
|
|
|
|
|
|
|
|
HOOD / Robinhood Markets, Inc.
|
|
|
|
|
|
|
|
TSHA / Taysha Gene Therapies, Inc.
|
|
|
|
|
|
|
|
GLUE / Monte Rosa Therapeutics, Inc.
|
|
|
|
|
|
|
|